The Importance of Demonstrating & Communicating Value of Your Drug Candidate
Time: 8:30 am
day: Day Two
Details:
- Debating how we present a case for reimbursement on life-limiting versus life-threatening disease
- Considering a multistakeholder perspective when communicating the value of your product
- Debating at which stage of drug development to begin thinking about/integrating the patient perspective
- Exploring quality of life surveys in clinical trials
- Patient-reported Outcomes: how do they vary between diseases?
